LONDON/TOKYO -- A coronavirus vaccine being developed by British pharmaceutical AstraZeneca and Oxford University showed a robust immune response in the early phases of its trial.
Coronavirus
AstraZeneca virus vaccine shows promise in trial
UK company expects to begin Japan tests in August
Some of the many vaccines being rushed through development are starting to show promise. © Reuters
Read Next
.JPG?width=700&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=394)
Latest on Coronavirus
